Clinical Trial: A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Locally Advanced Solid Tumor
Study Type: INTERVENTIONAL
Official Title: A First-in-Human, Open-Label, Multi-Center Phase 1 Study of TST003 in Subjects With Locally Advanced or Metastatic Solid Tumors
Brief Summary:
The goal of this clinical trial is to test the safety of TST003 in patients with cancer.The main question[s] it aims to answer are:What is the recommended dose patients can safely receive?How long does this drug remain in the body after administration?What are the side effects of this drug?Does your cancer respond to TST003?Participants on this study will get TST003 intravenously (through a needle into your vein), once every 3 weeks.You may need to come to the study site 2-4 times to have tests to see if you are…
Read more